ProAir HFA

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc., Lupin, Inc.

Conditions

AsthmaMild Persistent Asthma

Phase 2

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

CompletedNCT01899144

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2013-07-31End: 2013-10-31Updated: 2022-01-26

Phase 3

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

CompletedNCT02584257

Lupin, Inc.Mild Persistent Asthma

Start: 2016-04-30End: 2016-09-30Updated: 2020-12-04

Related Papers

Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma

Allergy and Asthma Proceedings2016-08-191 citations

Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma

Allergy and Asthma Proceedings2016-08-151 citations